Netrin-1 co-cross-linked hydrogel accelerates diabetic wound healing in situ by modulating macrophage heterogeneity and promoting angiogenesis

Futing Shu,Hongchao Huang,Shichu Xiao,Zhaofan Xia,Yongjun Zheng
DOI: https://doi.org/10.1016/j.bioactmat.2024.04.019
IF: 18.9
2024-05-27
Bioactive Materials
Abstract:Highlights • Netrin-1 was indispensable in normal wound healing. • Netrin-1 was aberrantly weakly expressed in diabetic wounds, potentially delaying wound healing. • Netrin-1 promoted macrophage heterogeneity via the A2bR/STAT/PPARγ signaling pathway in diabetic environment. • Topical netrin-1 application enhanced the angiogenesis in diabetic environment. • Netrin-1 co-cross-linked hydrogel in situ can accelerate diabetic wound healing. Diabetic wounds, characterized by prolonged inflammation and impaired vascularization, are a serious complication of diabetes. This study aimed to design a gelatin methacrylate (GelMA) hydrogel for the sustained release of netrin-1 and evaluate its potential as a scaffold to promote diabetic wound healing. The results showed that netrin-1 was highly expressed during the inflammation and proliferation phases of normal wounds, whereas it synchronously exhibited aberrantly low expression in diabetic wounds. Neutralization of netrin-1 inhibited normal wound healing, and the topical application of netrin-1 accelerated diabetic wound healing. Mechanistic studies demonstrated that netrin-1 regulated macrophage heterogeneity via the A2bR/STAT/PPARγ signaling pathway and promoted the function of endothelial cells, thus accelerating diabetic wound healing. These data suggest that netrin-1 is a potential therapeutic target for diabetic wounds. Graphical abstract Download : Download high-res image (393KB) Download : Download full-size image Netrin-1 co-crosslinked hydrogel accelerated diabetic wound healing in situ by modulating macrophage heterogeneity and promoting angiogenesis.
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?